Genomics Services Category Procurement Intelligence Report 2026-2030

The genomics services market covers a wide spectrum of offerings from basic whole genome sequencing to complex bioinformatics analysis, nutrigenomics testing, and other specialized genomic analysis services. In 2025, the market is valued at $47.07 billion, up from $44.52 billion in 2024, with projections to reach $85.09 billion by 2030. This represents a robust 12.6% compound annual growth rate, reflecting sustained demand across research, clinical, and consumer genomics applications.

• •Whole genome sequencing, a core segment, was valued at $2.1 billion in 2024 and continues to expand with projections reaching $6.7 billion
• •Nutrigenomics testing, a specialized consumer-facing segment, reached $0.58 billion in 2025 and is projected to grow to $1.14 billion
• •Bioinformatics services, supporting genomic data analysis and interpretation, represent a significant portion of the market valued at approximately $16.5 billion

The primary growth catalyst in genomics services is the ongoing reduction in DNA sequencing costs, making large-scale genomic analysis increasingly accessible to research institutions and healthcare providers. The convergence of genomics with precision medicine, which is expected to grow significantly through 2030, is creating expanded demand for genomic profiling and analysis services. Additionally, the broader big data analytics ecosystem supports the computational infrastructure needed to process and interpret the massive datasets generated by genomic sequencing.

• •Declining sequencing costs continue to drive adoption across research, clinical, and consumer applications
• •Precision medicine, growing at a 7.5% CAGR through 2030, relies heavily on genomic data analysis for patient-specific treatment approaches
• •Integration of artificial intelligence and big data technologies enables more efficient analysis of complex genomic datasets

The genomics services market encompasses multiple segments including whole genome sequencing, nutrigenomics testing, bioinformatics services, and various specialized genomic analysis offerings. While the market is global in scope, North America historically represents a significant share due to advanced healthcare infrastructure and substantial research investment, though Asia-Pacific is emerging as a rapidly growing region. The overall genomics market's projected growth to $85.09 billion by 2030 suggests broad geographic expansion across all major regions.

• •Nutrigenomics testing, a consumer-facing segment, is projected to grow at 14.3% CAGR from $0.58 billion in 2025 to $1.14 billion
• •Bioinformatics services, valued at approximately $16.5 billion, form a critical enabling technology for genomic data interpretation
• •Asia-Pacific markets are expected to show strong growth as sequencing infrastructure expands and research capabilities develop

What are the recent trends and outlook?

Looking ahead, the genomics services market is positioned for continued robust growth, with AI integration and automation expected to further streamline genomic data analysis workflows. The expanding applications of genomics in drug discovery, agricultural biotechnology, and consumer health services will diversify market opportunities beyond traditional research and clinical diagnostics. As the market approaches $85 billion by 2030, ongoing innovation in sequencing technology and data interpretation will likely sustain the 12.6% growth trajectory.

• •Integration of artificial intelligence into bioinformatics is accelerating the pace of genomic data interpretation
• •Consumer genomics and direct-to-consumer testing continue to gain traction globally
• •Pharmaceutical and biotechnology industries are increasingly incorporating genomic data into drug discovery and development pipelines